Tuesday, 3 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Price Movement Clarification

Vaishali Pharma Price Movement Clarification

Vaishali Pharma Limited clarified to the NSE that recent stock price fluctuations are purely market-driven. The company confirmed it has disclosed all material information under SEBI Regulation 30 and has no pending price-sensitive news. This response addresses an exchange surveillance query to ensure market transparency.

Source

NSE filing, NSE: VAISHALI. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Vaishali Pharma Ltd: key numbers

Share price
₹6.51
Market cap
₹87.88 Cr
Revenue (annual)
₹108.8 Cr
Net profit (annual)
₹4.16 Cr
P/E (TTM)
19.8×Sector 47.2×
Promoter holding
31.61%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Vaishali Pharma Ltd

All →

Other price movement clarification announcements

All →